Ajay Kakar, founder and CEO, Salve Pharma has spent nearly two decades building a premium Indian cosmetology and pharmaceutical brand.
The journey of Salve Pharmaceutical’s Pt. Ltd. began in 1935, when Kailash Chander Kakar established a modest retail pharmacy in Delhi’s Darya Ganj with the foundation of wooden counters, medicines and handwritten records, the small pharmacy eventually becomes a global healthcare enterprise.
Building on this steadfast and reputed pharmaceutical legacy, Ajay Kakar is now leading the next phase of growth through Salve Skin Sciences, with a vision to expand the groups presence in dermatology, skincare and global health industry.
Key Highlights
- The 20-Year Bootstrap-to-Scale Journey: Salve has evolved from a local marketing startup into a globally distributed pharmaceutical group.
- Manufacturing and R&D: The challenges, strategic execution, and business impact of setting up dedicated manufacturing and R&D to control product quality.
- Science-Led Product Innovation to break generic industry molds by introducing highly rare formulations in India, such as the advanced 42% Urea formulation for the Parasoft range and cutting-edge encapsulation nanotechnology in Sunprotek sunscreens.
- Future Plans & Vision 2030: Growth strategies to scale the manufacturing capacity and market reach of this Indian MSME over the next two years
- Encapsulates the MSME founder journey of starting from a local shop to skin care manufacture.
Read the full story that first appeared in The Global Indian here:
Leave a Reply